Show simple item record

dc.creatorJatuworapruk, Kanon
dc.creatorMontgomery, Anna
dc.creatorGianfrancesco, Milena
dc.creatorConway, Richard
dc.creatorDurcan, Laura
dc.creatorGraef, Elizabeth R.
dc.creatorJayatilleke, Arundathi
dc.creatorKeen, Helen
dc.creatorKilian, Adam
dc.creatorYoung, Kristen
dc.creatorCarmona, Loreto
dc.creatorCogo, Adriana Karina
dc.creatorDuarte-Garcia, Ali
dc.creatorGossec, Laure
dc.creatorHasseli, Rebecca
dc.creatorHyrich, Kimme L.
dc.creatorLanglois, Vincent
dc.creatorSigurdardottir, Valgerdur
dc.creatorSparks, Jeffrey A.
dc.creatorStrangfeld, Anja
dc.creatorXavier, Ricardo M.
dc.creatorBhana, Suleman
dc.creatorGore-Massy, Monique
dc.creatorHausmann, Jonathan S.
dc.creatorLiew, Jean W.
dc.creatorSirotich, Emily
dc.creatorSufka, Paul
dc.creatorWallace, Zach
dc.creatorMachado, Pedro M.
dc.creatorYazdany, Jinoos
dc.creatorGrainger, Rebecca
dc.creatorRobinson, Philip C.
dc.identifier.citationJatuworapruk, K., Montgomery, A., Gianfrancesco, M., Conway, R., Durcan, L., Graef, E.R., Jayatilleke, A., Keen, H., Kilian, A., Young, K., Carmona, L., Cogo, A.K., Duarte-García, A., Gossec, L., Hasseli, R., Hyrich, K.L., Langlois, V., Lawson-Tovey, S., Malcata, A., Mateus, E.F., Schafer, M., Scirè, C.A., Sigurdardottir, V., Sparks, J.A., Strangfeld, A., Xavier, R.M., Bhana, S., Gore-Massy, M., Hausmann, J., Liew, J.W., Sirotich, E., Sufka, P., Wallace, Z., Machado, P.M., Yazdany, J., Grainger, R. and Robinson, P.C. (2022), Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. ACR Open Rheumatology, 4: 948-953.
dc.description.abstractObjective: To describe people with gout who were diagnosed with coronavirus disease 2019 (COVID-19) and hospitalized and to characterize their outcomes. Methods: Data on patients with gout hospitalized for COVID-19 between March 12, 2020, and October 25, 2021, were extracted from the COVID-19 Global Rheumatology Alliance registry. Descriptive statistics were used to describe the demographics, comorbidities, medication exposures, and COVID-19 outcomes including oxygenation or ventilation support and death. Results: One hundred sixty-three patients with gout who developed COVID-19 and were hospitalized were included. The mean age was 63 years, and 85% were male. The majority of the group lived in the Western Pacific Region (35%) and North America (18%). Nearly half (46%) had two or more comorbidities, with hypertension (56%), cardiovascular disease (28%), diabetes mellitus (26%), chronic kidney disease (25%), and obesity (23%) being the most common. Glucocorticoids and colchicine were used pre-COVID-19 in 11% and 12% of the cohort, respectively. Over two thirds (68%) of the cohort required supplemental oxygen or ventilatory support during hospitalization. COVID-19-related death was reported in 16% of the overall cohort, with 73% of deaths documented in people with two or more comorbidities. Conclusion: This cohort of people with gout and COVID-19 who were hospitalized had high frequencies of ventilatory support and death. This suggests that patients with gout who were hospitalized for COVID-19 may be at risk of poor outcomes, perhaps related to known risk factors for poor outcomes, such as age and presence of comorbidity.
dc.format.extent6 pages
dc.relation.ispartofCOVID-19 Research
dc.relation.haspartACR Open Rheumatology, Vol. 4, No. 11
dc.relation.isreferencedbyWiley Open Access
dc.rightsAttribution-NonCommercial-NoDerivs CC BY-NC-ND
dc.titleCharacteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
dc.type.genreJournal article
dc.description.departmentSection of Rheumatology
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact
dc.description.schoolcollegeLewis Katz School of Medicine
dc.temple.creatorJayatilleke, Arundathi

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND